Results 31 to 40 of about 142,623 (303)

Impact of anticoagulation and antiplatelet therapy on dialysis catheter fibrin sheath formation [PDF]

open access: yes, 2022
PURPOSEFibrin sheaths are a significant cause of dialysis catheter dysfunction. This study aimed to determine the role of anticoagulation, antiplatelet medications, and other factors in delaying fibrin sheath formation.METHODSAn institutional review ...
Forrest B. Linch   +5 more
core   +1 more source

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

open access: yesHealth Technology Assessment, 2013
Background: Previous research suggests uncertainty whether or not there is any additional benefit in adding antiplatelet therapy (APT) to anticoagulation therapy (ACT) in patients with high-risk atrial fibrillation (AF) in terms of reduction in vascular ...
DA Lane   +6 more
doaj   +1 more source

Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics

open access: yesJournal of Minimal Access Surgery, 2019
Aims: We aimed to evaluate the safety and feasibility of laparoscopic total extraperitoneal (TEP) inguinal hernia repair in patients with the continuation of their antithrombotic agents. Settings and Design: This was prospective cohort study.
Chen-Hsun Ho   +3 more
doaj   +1 more source

Effects of Periprocedural Tirofiban vs. Oral Antiplatelet Drug Therapy on Posterior Circulation Infarction in Patients With Acute Intracranial Atherosclerosis-Related Vertebrobasilar Artery Occlusion

open access: yesFrontiers in Neurology, 2020
Background and purpose: Tirofiban and oral antiplatelet drugs can be used to inhibit reocclusion and restore microvascular reperfusion during endovascular treatment (EVT).
Xuan Sun   +5 more
doaj   +1 more source

Drug interactions and hepatotoxicity of clopidogrel [PDF]

open access: yes, 2010
Clopidogrel (Plavix¨) is an antiplatelet drug, which is clinically used in combination with aspirin to reduce cardiovascular events in patients undergoing percutaneous coronary intervention or in patients suffering from acute coronary syndromes ...
Zahno, Anja-Christina
core   +1 more source

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention [PDF]

open access: yes, 2020
Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual ...
Dimitrios Alexopoulos   +2 more
core   +1 more source

Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study. [PDF]

open access: yes, 2023
BACKGROUND Statin medication has been identified as a potential therapeutic target for stabilizing cerebral cavernous malformations (CCMs). Although increasing evidence suggests that antiplatelet medication decreases the risk of CCM hemorrhage, data ...
Mattia Branca   +11 more
core   +1 more source

Secondary prevention of coronary heart disease in older patients after the national service framework: population based study [PDF]

open access: yes, 2006
Objective To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework.Design Two population based,
Morris, RW   +15 more
core   +1 more source

Challenges in the Management of Major Hemorrhage after Hemorrhoidal Banding

open access: yesWorld Journal of Colorectal Surgery, 2021
Hemorrhoidal banding is considered a safe, low-risk technique for the management of grade-I–III internal hemorrhoids. Furthermore, information in the literature regarding serious complications associated with banding is limited.
Kabytto Chen   +2 more
doaj   +1 more source

Congenital anomaly of coronary artery: absence of left circumflex artery

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2019
The prevalence of congenital coronary artery anomalies is approximately 1% in the general population. They are a common cause of sudden death in younger persons. Congenital absence of the left circumflex artery is usually a benign condition but can cause
Muhammad Shabbir Rawala   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy